SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 253G2 -
SEC Accession No. 0001104659-20-042074
Filing Date
2020-04-02
Accepted
2020-04-01 21:53:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 253G2 tm2014812-1_253g2.htm 253G2 25254
2 GRAPHIC image_001.jpg GRAPHIC 6741
  Complete submission text file 0001104659-20-042074.txt   35769
Mailing Address 505 IRVING AVENUE SUITE 3100 A-B SYRACUSE NY 13210
Business Address 505 IRVING AVENUE SUITE 3100 A-B SYRACUSE NY 13210 607-227-4400
Quadrant Biosciences Inc (Filer) CIK: 0001651239 (see all company filings)

IRS No.: 473417864 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 253G2 | Act: 33 | File No.: 024-11155 | Film No.: 20767250
SIC: 2834 Pharmaceutical Preparations